Atterocor Begins Phase 1 Trial for Adrenal Cancer Drug

Published November 13, 2013

Atterocor Begins Phase 1 Trial for Adrenal Cancer Drug
The Ann Arbor, MI-based biotech startup Atterocor announced last week that it has initiated a Phase 1 clinical trial of ATR-101, a novel drug candidate to treat adrenal cancer. In pre-clinical studies, ATR-101 has shown … “The approved treatment …
Read more on Xconomy

UM Study: “Smarter” blood pressure guidelines could prevent many more heart …
A new way of using blood pressure-lowering medications could prevent more than a fourth of heart attacks and strokes – up to 180,000 a year – while using less medication overall, according to new research from the University of Michigan Health System …
Read more on University of Michigan Health System News (press release)

Nov. 7, 2013 City Council: Live Updates
An additional project related to non-motorized issues, but not obviously so, is a contract with the Michigan Dept. of Transportation to resurface a portion of Huron Street from Main Street westward as Huron becomes Jackson Avenue on to I-94, as well as …
Read more on The Ann Arbor Chronicle

Michigan Rehab Centers — Rehab.

More Drug Treatment Centers In Michigan Information…